Approach to acute gastroenteritis in adults and children as per latest guidelines

Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

"Gastroenteritis"[MeSH Terms] AND "Practice Guideline"[Publication Type]

Searching PubMed

"Gastroenteritis"[MeSH Terms] AND rehydration

Searching the Web

acute infectious diarrhea adults children guidelines oral rehydration CDC IDSA ESPGHAN 2025

Reading File
Reading File
Reading File
Reading Web Page

https://www.idsociety.org/practice-guideline/infectious-diar…

Reading Article

PMID: 41109838

Acute gastroenteritis (AGE): practical approach for adults and children

AGE is acute-onset diarrhea, often with vomiting, abdominal cramps, and fever, usually caused by viral infection and usually self-limited. The first priority is identifying dehydration, sepsis, dysentery, or a surgical/noninfectious mimic, not identifying the organism in every patient. Norovirus is a leading cause across age groups. ROSEN's Emergency Medicine, p. 1300.

1. Immediate triage: who needs urgent assessment or admission?

Assess airway, breathing, circulation, mental state, glucose when indicated, urine output, and hydration.
Red flags
  • Shock, altered consciousness, poor perfusion, oliguria/anuria, inability to drink or persistent vomiting
  • Severe dehydration: lethargy, very dry mucosa, sunken eyes, weak pulses, prolonged capillary refill, hypotension
  • Bloody diarrhea, high fever, severe abdominal pain, guarding, distension, or peritonitis
  • Sepsis or suspected enteric fever
  • Infants, especially <3 months, older/frail adults, pregnancy, immunocompromise, significant renal/cardiac disease
  • Recent antibiotics or healthcare exposure, raising concern for Clostridioides difficile
  • Persistent diarrhea for ≥14 days, substantial weight loss, or failed outpatient oral rehydration
  • Outbreak, food-handler, childcare, institutional, or travel-related illness
In children, dehydration risk is higher with young age, frequent high-volume stool losses, persistent vomiting, reduced tears/urine, sunken eyes, or altered behavior. ROSEN's Emergency Medicine, p. 1300.

2. Focused clinical assessment

History

Ask about:
  • Onset, stool frequency/volume, watery versus bloody or mucoid stool, vomiting, fever, pain
  • Fluid intake, urine output, weight loss, ability to drink
  • Food exposures: undercooked poultry/eggs, unpasteurized products, seafood, buffet food
  • Travel, unsafe water, swimming/recreational-water exposure
  • Sick contacts, daycare, healthcare/institutional exposure, outbreaks
  • Recent antibiotics, proton-pump inhibitors, hospitalization
  • Comorbidity, immunosuppression, pregnancy
  • Medications and possible noninfectious causes

Examination

  • Hydration: appearance, mucous membranes, tears, eyes, pulse, capillary refill, postural symptoms, skin perfusion, urine output
  • Temperature and vital signs
  • Abdominal examination for focal tenderness, guarding, distension, toxic megacolon
  • Consider alternate diagnoses: appendicitis, intussusception in children, bowel obstruction, inflammatory bowel disease, diabetic ketoacidosis, urinary infection, pelvic pathology, ischemic colitis, adrenal crisis, poisoning.

3. Rehydration and feeding: treatment for nearly everyone

Mild to moderate dehydration

Use a commercial reduced-osmolarity oral rehydration solution (ORS). It is first-line in infants, children, and adults, including patients with vomiting if given in small frequent volumes. Sodium-glucose cotransport remains functional during infectious diarrhea, which is why ORS works. The IDSA guideline recommends ORS as initial rehydration treatment across age groups.
  • Give frequent, small sips or spoonfuls, escalating as tolerated.
  • In a vomiting child, give very small amounts frequently rather than stopping all fluids.
  • Nasogastric ORS is an option if oral intake is inadequate but the gut is functioning.
  • Avoid using cola, undiluted juice, energy drinks, and sports drinks as rehydration therapy. Their sodium-glucose composition is unsuitable and excess sugar can worsen diarrhea.

Severe dehydration, shock, or failed ORS

  • Urgent IV isotonic crystalloid resuscitation and electrolyte/glucose assessment.
  • Reassess frequently, then transition to ORS as soon as possible.
  • Admit if ongoing losses, poor oral intake, concerning comorbidity, unreliable follow-up, or diagnostic uncertainty.

Nutrition

  • Resume an age-appropriate usual diet early once rehydration begins.
  • Continue breastfeeding without interruption.
  • Do not routinely use bowel rest, clear-fluid-only diets, lactose-free formula, or restricted diets.
  • Avoid high-sugar beverages and highly fatty foods initially.
Early feeding supports absorption and recovery. ROSEN's Emergency Medicine, p. 1300. The CDC pediatric guidance likewise emphasizes ORS plus early nutritional support.

4. When to investigate

Most uncomplicated, short-duration watery diarrhea needs no tests.

Send stool testing, ideally multiplex PCR with culture/public-health follow-up when indicated, if:

  • Fever, blood or mucus in stool, severe cramps or abdominal tenderness
  • Sepsis or systemic toxicity
  • Severe illness, significant dehydration, hospitalization
  • Immunocompromise or major comorbidity
  • Recent travel, suspected cholera, outbreak, foodborne exposure, or public-health implications
  • Persistent diarrhea, generally ≥14 days
  • Suspected C. difficile: recent antibiotics, hospitalization, or healthcare exposure
For inflammatory diarrhea, evaluate for Salmonella, Shigella, Campylobacter, Yersinia, STEC/Shiga toxin, and other pathogens according to exposure. Specifically request Shiga-toxin/STEC testing where it is not automatically included.

Additional tests

  • CBC, electrolytes, renal function, glucose, blood gas if severe dehydration, significant illness, or sepsis is suspected.
  • Blood cultures for sepsis, suspected enteric fever, systemic infection, high-risk immunocompromise, and selected very young infants.
  • Ova/parasite testing or pathogen-specific testing for persistent disease, relevant travel, untreated water exposure, or immunocompromise.
The 2025 pediatric consensus recommends microbiological testing mainly for prolonged/complicated AGE or patients with risk factors, and discourages routine empirical antibiotics. Berghezan-Suárez et al., 2025, PMID 41109838

5. Antimicrobials: targeted, not routine

Do not routinely prescribe antibiotics

Most AGE is viral or self-limited. Antibiotics can cause adverse effects, C. difficile, antimicrobial resistance, and prolonged carriage in some infections.
In particular:
  • Do not treat uncomplicated watery diarrhea empirically.
  • Do not routinely treat uncomplicated nontyphoidal Salmonella.
  • Avoid antibiotics when STEC is suspected or confirmed, especially bloody diarrhea after undercooked beef or outbreak exposure, because they may increase the risk of hemolytic uremic syndrome. ROSEN's Emergency Medicine, p. 1300.

Consider empiric antibiotics only in selected severe/high-risk cases

Use local resistance data and obtain cultures first whenever feasible.
Examples:
  • Presumed shigellosis with classic dysentery and marked systemic illness
  • Recent international travel plus fever ≥38.5 C, sepsis, or severe disease
  • Severe illness in immunocompromised patients
  • Infant <3 months with suspected invasive bacterial enteritis
  • Suspected cholera with severe high-output diarrhea after rehydration has started
  • Suspected enteric fever or sepsis
Then narrow, stop, or modify treatment once microbiology and susceptibilities return. For drug selection, local/national antimicrobial guidance matters because resistance patterns vary.

6. Symptomatic medicines

InterventionAdultsChildren
OndansetronMay help vomiting and enable ORS in selected patientsA single supervised dose may help children who cannot retain ORS. Watch for increased diarrhea and QT-risk factors.
LoperamideMay be considered for immunocompetent adults with uncomplicated, afebrile, non-bloody watery diarrheaAvoid. Do not use in infants and children.
Loperamide avoidanceAvoid with fever, bloody/inflammatory diarrhea, suspected STEC, C. difficile, ileus, severe colitis, or toxic appearanceAvoid
BismuthMay offer limited benefit in selected adults, including some travelersAvoid in children/adolescents with viral illness because of salicylate-related risk; avoid with salicylate allergy/anticoagulation.
ProbioticsNot routineMay be considered only in otherwise healthy children if a specific evidence-based product is available; avoid in critically ill, central-line, or immunocompromised patients because rare bacteremia/fungemia has occurred.
ZincNot routinely used in well-nourished adultsMainly relevant in resource-limited settings or malnutrition, consistent with local/WHO programs.
Antiemetics should facilitate ORS, not replace fluids and nutrition. The IDSA guideline notes that loperamide can reduce stool volume in healthy adults with watery diarrhea, but should not be used for inflammatory syndromes; it also supports cautious ondansetron use to enable oral intake.

7. Differences in approach

Adults

  • Think particularly about traveler's diarrhea, medication-associated diarrhea, C. difficile, ischemic colitis in older adults, and inflammatory bowel disease.
  • Antimotility medication is an option only for simple watery illness with no red flags.
  • Older adults can deteriorate quickly because dehydration may precipitate acute kidney injury, delirium, or heart failure.

Children

  • Prioritize rapid hydration assessment and ongoing urine output.
  • ORS, breastfeeding, and early normal feeding are the core treatment.
  • Lower threshold for escalation in infants, especially <6 months or <8 kg, premature children, or those with chronic disease.
  • Avoid loperamide and routine antibiotics.
  • Evaluate bloody diarrhea carefully for STEC and monitor for HUS: reduced urine, pallor, bruising, lethargy, edema, or hypertension.

8. Discharge advice and infection control

Discharge is reasonable when the patient is alert, adequately perfused, drinking enough to match losses, has caregivers able to give ORS, and has reliable follow-up.
Advise return urgently for:
  • Reduced urine output, inability to drink, repeated vomiting
  • Lethargy, fainting, confusion, worsening weakness
  • Blood in stool, persistent high fever, severe/localized abdominal pain
  • Diarrhea lasting >7 days without improvement, or ≥14 days overall
  • In children: no tears, sunken eyes, fewer wet diapers, unusual sleepiness/irritability.
Prevent spread:
  • Handwashing with soap and water after toileting/diaper changes and before food preparation.
  • Do not prepare food for others while symptomatic.
  • Keep children out of childcare and workers out of food handling according to local regulations.
  • Use chlorine-based cleaning for norovirus-contaminated surfaces when feasible.
  • Maintain appropriate routine vaccines, including rotavirus vaccine in eligible infants.

Current-guideline note

The major IDSA infectious-diarrhea guideline remains the practical broad framework for both adults and children, supplemented by newer pathogen- and region-specific guidance. A 2025 pediatric consensus continues to support selective testing and very limited empiric antibiotic use. A recent probiotic meta-analysis, PMID 40535538, evaluated a specific Saccharomyces boulardii product in Chinese pediatric studies and does not justify routine probiotic use for all children with AGE.

With drug dosage

Reading File
Finding Sources
Finding Sources
Searching PubMed

acute gastroenteritis child adult treatment guideline

Searching PubMed

infectious diarrhea treatment systematic review

Searching the Web

acute gastroenteritis treatment doses ondansetron oral rehydration azithromycin ciprofloxacin adults children guideline

Reading File
Reading File
Reading Web Page

https://www.idsociety.org/practice-guideline/infectious-diar…

Acute gastroenteritis: management with commonly used doses

Use this as a clinical reference, not a substitute for patient-specific prescribing. Fluid choice, antibiotic choice, renal function, age, pregnancy, ECG/QT risk, local resistance, and confirmed pathogen all matter.
Most acute gastroenteritis is viral and needs oral rehydration plus early feeding, not antibiotics. Antibiotics are reserved for selected invasive, severe, travel-associated, septic, high-risk, or microbiologically confirmed infections.

1. Rehydration

A. Oral rehydration solution (ORS)

Use a reduced-osmolarity commercial ORS. Avoid plain water alone for significant losses, undiluted juices, fizzy drinks, sports drinks, and overly sweet fluids.

Adults

  • Mild illness: small frequent sips, aiming to replace ongoing losses.
  • Practical replacement: 200-250 mL ORS after each loose stool and additional fluid after vomiting, as tolerated.
  • If vomiting: give 5-10 mL every 1-2 minutes, increasing gradually.

Children

Clinical stateORS dose
No clinical dehydrationContinue usual fluids/breastfeeding; give ORS after each loss
Mild to moderate dehydration50-100 mL/kg over 3-4 hours
Replacement of ongoing stool loss10 mL/kg per loose stool
Replacement after vomiting2 mL/kg per emesis episode
If vomiting prevents drinking5 mL every 1-2 minutes by spoon/syringe, then increase as tolerated
For a 10-kg child with mild-moderate dehydration: give 500-1000 mL over 3-4 hours, reassessing hydration and urine output. Tintinalli's Emergency Medicine, Initial Treatment of Dehydration.
Continue breastfeeding and restart normal age-appropriate feeding once rehydration begins.

B. IV fluids

Indications: shock, severe dehydration, altered sensorium, failed ORS/NG rehydration, persistent large-volume vomiting, ileus, or inability to drink.

Adults

  • 0.9% saline or Ringer lactate: usually 1 L IV bolus, then reassess perfusion, blood pressure, lung status, urine output, and electrolytes.
  • In severe hypovolemia/shock, repeat boluses as required under close monitoring.
  • Use smaller boluses and more frequent reassessment in heart failure, advanced kidney disease, frail older adults, and pregnancy.

Children

  • 0.9% saline or Ringer lactate 20 mL/kg IV over 5-20 minutes for shock/severe dehydration, then reassess.
  • Repeat if shock persists, while urgently checking glucose and electrolytes.
  • Once circulation improves, complete rehydration and switch to ORS as soon as feasible.
Tintinalli's Emergency Medicine describes 20 mL/kg isotonic fluid boluses in severe pediatric dehydration and a total early replacement target of roughly 60-100 mL/kg, individualized to reassessment.

2. Antiemetic

Ondansetron

Use mainly to facilitate ORS in a vomiting patient with mild-moderate dehydration or failed initial ORS. It is not a replacement for fluid therapy.

Children, usually age ≥6 months

Single oral dose:
  • 8-15 kg: 2 mg PO/ODT once
  • 15-30 kg: 4 mg PO/ODT once
  • >30 kg: 8 mg PO/ODT once
Alternative weight-based dose:
  • 0.15 mg/kg PO or IV once, maximum 8 mg
Start ORS about 15-30 minutes later. A further dose is sometimes used if vomiting occurs immediately after dosing, but routine multidose outpatient therapy is generally avoided.

Adults

  • 4-8 mg PO/ODT or IV once, then use only selectively, for example every 8-12 hours as needed for a very short period.

Avoid or use with particular caution

  • Congenital long-QT syndrome
  • Significant hypokalemia or hypomagnesemia
  • Concomitant QT-prolonging drugs
  • Known arrhythmia or severe cardiac disease
  • Suspected bowel obstruction, bilious vomiting, or surgical abdomen
Ondansetron may increase diarrhea frequency. The AAFP pediatric review gives the practical weight-band doses above; ROSEN's Emergency Medicine, p. 1300 supports 0.15 mg/kg, maximum 8 mg, to facilitate ORT.
Avoid routine promethazine, prochlorperazine, and metoclopramide in children because adverse effects can outweigh benefits.

3. Antidiarrheal drugs

Loperamide: adults only

For an immunocompetent adult with uncomplicated, afebrile, non-bloody watery diarrhea:
  • 4 mg PO initially
  • Then 2 mg PO after each unformed stool
  • Maximum 16 mg/day
  • Stop once stools are formed or if no improvement within 48 hours.
Do not use loperamide in:
  • Children
  • Fever or bloody/mucoid stool
  • Suspected invasive bacterial diarrhea, dysentery, STEC, or C. difficile
  • Severe colitis, abdominal distension, ileus, toxic appearance
  • Acute ulcerative colitis flare
Goldman-Cecil Medicine, Table 26-5 lists 4 mg initially then 2 mg after each unformed stool, maximum 16 mg/day, with avoidance in fever or bloody/mucoid stool.

Bismuth subsalicylate: selected adults

  • 524 mg PO every 30-60 minutes as needed
  • Maximum 8 doses in 24 hours
  • Use for a maximum of about 2 days without reassessment.
Avoid in:
  • Children/adolescents with viral illness
  • Aspirin/salicylate allergy
  • Anticoagulant use or significant bleeding risk
  • Significant renal impairment
  • Pregnancy unless specifically advised
It can cause harmless black tongue or stool.

4. Antibiotics

Key principle

Do not prescribe empiric antibiotics for routine acute watery diarrhea. Test and treat selectively.
Avoid antibiotics in suspected or proven Shiga toxin-producing E. coli (STEC), especially bloody diarrhea after undercooked beef or an outbreak, because antibiotic exposure may raise the risk of hemolytic uremic syndrome. ROSEN's Emergency Medicine, p. 1300.

Consider empiric treatment only if there is:

  • Sepsis, suspected enteric fever, or severe systemic disease
  • Severe traveler-associated fever/dysentery
  • Severe immunocompromise
  • Selected young infants with suspected invasive bacterial AGE
  • Clinically severe presumed shigellosis
  • Suspected cholera with high-output diarrhea, after fluid resuscitation begins
Obtain stool testing and cultures before antibiotics whenever feasible.

A. Adults: common empiric regimens

Febrile diarrhea or dysentery, especially travel-associated

Azithromycin
  • 1 g PO once, or
  • 500 mg PO once daily for 3 days
Often preferred for travel in South or Southeast Asia and for suspected Campylobacter, where fluoroquinolone resistance is common.
Alternative only when susceptibility/travel setting makes it reasonable:
Ciprofloxacin
  • 500 mg PO every 12 hours for 3 days
or
Levofloxacin
  • 500 mg PO once daily for 3 days
Avoid fluoroquinolones when possible in pregnancy and use caution in patients at risk of tendinopathy, aortic disease, QT prolongation, neuropathy, or significant CNS adverse effects.

Noninvasive traveler's diarrhea only

Rifaximin
  • 200 mg PO three times daily for 3 days
Do not use rifaximin if there is fever, blood in stool, or suspected invasive diarrhea.
Goldman-Cecil Medicine, Table 26-5 lists azithromycin 1 g once or 500 mg daily for 3 days; ciprofloxacin 500 mg twice daily for 3 days; levofloxacin 500 mg daily for 3 days; and rifaximin 200 mg three times daily for 3 days only for noninvasive traveler's diarrhea.

B. Children: antibiotics only after pediatric assessment

Children should not receive empiric antibiotics for most AGE. Dose selection must use body weight, age, illness severity, renal/hepatic function, local susceptibility, and pathogen.

Selected suspected/confirmed bacterial invasive diarrhea

Azithromycin
  • 10 mg/kg PO once daily for 3 days, maximum 500 mg/dose
Some protocols use:
  • 10-12 mg/kg on day 1, then
  • 5-6 mg/kg once daily on days 2-3 or 2-5
Use for selected Campylobacter, Shigella, or travel-associated bacterial diarrhea, guided by local resistance and stool results.
Ceftriaxone, if severe disease, sepsis, inability to take oral medication, or selected invasive bacterial infection:
  • 50-75 mg/kg IV once daily
  • Maximum commonly 2 g/day
  • Duration depends entirely on pathogen and clinical syndrome.
Cefixime, selected oral alternative when indicated by susceptibility:
  • 8 mg/kg/day PO in 1-2 divided doses
  • Maximum 400 mg/day
  • Typical duration: 3-5 days, pathogen-dependent.
Avoid routine ciprofloxacin in children. It is reserved for situations where safer effective alternatives are unavailable or resistance requires it, under specialist/local guidance.
The 2025 pediatric AGE consensus, PMID 41109838, states that empirical antibiotics should generally not be started except in selected situations such as young infants with suspected bacterial disease, sepsis, underlying disease, institutional risk of spread, or risk of dissemination.

5. Pathogen-directed examples

Likely or confirmed pathogenUsual approach
Viral AGE, including norovirus/rotavirusORS, nutrition, no antibiotic
STEC / E. coli O157ORS, monitor for HUS, no antibiotic or loperamide
Nontyphoidal SalmonellaUsually no antibiotic; treat selected high-risk or invasive illness only
Campylobacter with severe/prolonged disease or high-risk hostAzithromycin is commonly preferred
ShigellaAntibiotics are often appropriate when confirmed or strongly suspected, guided by susceptibility
Cholera with significant dehydrationAggressive ORS/IV rehydration first; antibiotic may shorten illness and shedding
C. difficileTest if appropriate. Do not treat with standard AGE antibiotics. Requires a separate regimen based on current CDI guidance
Giardia, Entamoeba, CryptosporidiumConfirm where possible and use organism-specific therapy rather than empiric broad antibiotics

6. Zinc and probiotics

Zinc, mainly in resource-limited settings or malnutrition

For children with acute diarrhea in settings where WHO-style zinc supplementation is recommended:
  • Age <6 months: elemental zinc 10 mg PO daily for 10-14 days
  • Age ≥6 months: elemental zinc 20 mg PO daily for 10-14 days
Zinc is not routinely used for well-nourished children in high-income settings.

Probiotics

Do not prescribe a generic “probiotic dose” because effects depend on a specific strain and formulation, and evidence is inconsistent. Avoid in critically ill or immunocompromised patients and those with central lines because rare bloodstream infections occur. Recent evidence does not support universal routine use.

7. When to refer urgently or admit

  • Shock, altered consciousness, or severe dehydration
  • Oliguria/anuria, acute kidney injury, severe electrolyte disturbance
  • Bilious vomiting, guarding, focal severe pain, abdominal distension
  • Bloody stool with systemic illness
  • Suspected HUS: pallor, reduced urine, bruising, edema, hypertension after bloody diarrhea
  • Infant <3 months with fever or suspected invasive infection
  • Older/frail adult, immunocompromised patient, pregnancy, major renal/cardiac disease
  • Failure of ORS plus antiemetic or inability to ensure safe follow-up
The IDSA infectious-diarrhea guideline supports reduced-osmolarity ORS as first-line treatment for mild-moderate dehydration at all ages and selective, rather than routine, antibiotic therapy.
This is a shared conversation. Sign in to Orris to start your own chat.